Ghanayem B I
Toxic Rep Ser. 2000 May(47):1-56, A1-E6.
Methacrylonitrile is an aliphatic nitrile used extensively in the preparation of homo- and copolymers, elastomers, and plastics and as a chemical intermediate in the preparation of acids, amides, esters, and other nitriles. This aliphatic nitrile is also used as a replacement for acrylonitrile in the manufacture of an acrylonitrile/butadiene/styrene-like polymer. Methacrylonitrile was nominated for toxicity and carcinogenicity testing by the National Cancer Institute due to its high production volume and extensive use, the lack of chronic or carcinogenicity data, and its structural resemblance to the known rat carcinogen acrylonitrile. The current 13-week studies were conducted as part of an overall effort by the NTP to assess the toxicity and carcinogenicity of methacrylonitrile. During the 13-week studies, groups of 20 male and 20 female F344/N rats were administered 0, 7.5, 15, 30, 60, or 120 mg methacrylonitrile/kg body weight in deionized, purified water by gavage. Groups of 20 male and 20 female B6C3F1 mice were administered 0, 0.75, 1.5, 3, 6, or 12 mg/kg methacrylonitrile. Ten male and ten female rats and mice from each group were evaluated on day 32. The results of these studies clearly revealed that male rats are more sensitive than females to methacrylonitrile treatment. In the rat study, 19 males and one female administered 120 mg/kg and two males administered 60 mg/kg died during the first week of the study. Males in the 60 mg/kg group at the 32-day interim evaluation and at 13 weeks and females in the 120 mg/kg group at 13 weeks had significantly lower final mean body weights and body weight gains than did the vehicle controls; the surviving male in the 120 mg/kg group also weighed less than the controls at the 32-day interim evaluation. Clinical findings of toxicity were dose dependent and included lethargy, lacrimation, tremors, convulsions, ataxia, and abnormal breathing. There was hematologic evidence indicating that administration of methacrylonitrile induced minimal, normocytic, normochromic anemia. At the 32-day interim evaluation, a minimal dose-related anemia was evidenced by decreases in hematocrit values, hemoglobin concentrations, and erythrocyte counts in male and female rats. The anemia ameliorated by week 13. Administration of methacrylonitrile resulted in dose-related increases in serum thiocyanate and blood cyanide concentrations of male and female rats. These changes were expected and would be consistent with the in vivo metabolism of methacrylonitrile to cyanide. Blood cyanide concentrations were generally higher in males than in females, which may explain the higher sensitivity of males to the lethal effect of methacrylonitrile. There was also biochemical evidence of increased hepatocellular leakage and/or altered function in dosed male rats, suggesting that the liver may be a target organ for toxic effects of methacrylonitrile. Minimal, but significant, decreases in absolute right kidney and thymus weights (32-day interim evaluation) and increases in liver and stomach weights (week 13) occurred in male rats that received 60 mg/kg compared to the vehicle controls. In female rats, stomach weights of the 60 and 120 mg/kg groups were significantly greater and thymus weights of the 120 mg/kg group were significantly less than those of the controls on day 32 and at week 13; liver weights were also significantly greater in females in the 120 mg/kg group than in the vehicle controls on day 32. Male and female rats administered 60 mg/kg and females administered 120 mg/kg had significantly greater incidences of metaplasia of the nasal olfactory epithelium on day 32 and at the end of the study than did the vehicle controls; incidences of olfactory epithelial necrosis were also significantly greater in females in the 60 and 120 mg/kg groups than in the vehicle controls on day 32. Incidence and/or severity increased with increasing dose in females; however, the mortality in male rats administered 120 mg/kg made it difficult to assess the dose-response relationship in males. The no-observed-adverse-effect level for the nasal cavity of rats was 30 mg/kg. Female rats administered 60 or 120 mg/kg methacrylonitrile had significantly longer estrous cycles than did the vehicle controls. Females in the 60 mg/kg group spent more time in diestrus than the vehicle controls. One male and one female mouse in the 12 mg/kg groups died early. Methacrylonitrile administration caused no significant differences in final mean body weights or body weight gains. Clinical findings included lethargy, tremors, ataxia, convulsions, and abnormal breathing. At the 32-day interim evaluation, stomach weights of males administered 3 mg/kg or greater were significantly greater and thymus weights of males in the 12 mg/kg group were significantly less than those of the vehicle controls. At week 13, however, the stomach weights of only males in the 12 mg/kg group were increased relative to the vehicle controls. No treatment-related histopathologic lesions occurred in mice. Methacrylonitrile did not induce mutations in any of several strains of Salmonella typhimurium, with or without S9 activation, and did not induce sex-linked recessive lethal mutations in germ cells of male Drosophila melanogaster fed methacrylonitrile during the larval stage. Results of in vivo bone marrow micronucleus tests with methacrylonitrile in male rats and mice were also negative. In summary, gavage administration of methacrylonitrile to rats and mice resulted in dose-dependent lethargy, tremors, lacrimation, convulsions, and abnormal breathing. However, these effects were more pronounced in rats than mice; these differences may be attributed to the higher doses of methacrylonitrile administered to rats. Body weight gain and survival data of rats demonstrated that males are more sensitive to methacrylonitrile dosing than females. There is an apparent correlation between blood cyanide concentrations and survival rates, with males having greater cyanide concentrations and lower survival rates than female rats administered methacrylonitrile. Microscopically, the only target of methacrylonitrile toxicity was the olfactory epithelium of the nasal cavity. Necrotic and metaplastic effects were induced in male and female rats that received 60 or 120 mg/kg per day. No similar lesions were observed in mice administered methacrylonitrile. The no-observed-adverse-effect level for olfactory epithelial lesions in male and female rats administered methacrylonitrile for 13 weeks was 30 mg/kg per day. No clear chemical-related effects were observed in male or female mice administered methacrylonitrile for 13 weeks by gavage at doses up to 12 mg/kg per day.
甲基丙烯腈是一种脂肪族腈类化合物,广泛用于制备均聚物和共聚物、弹性体及塑料,并作为制备酸、酰胺、酯和其他腈类化合物的化学中间体。这种脂肪族腈类化合物还被用作制造一种类似丙烯腈/丁二烯/苯乙烯聚合物时丙烯腈的替代品。由于甲基丙烯腈产量高、用途广泛、缺乏慢性毒性或致癌性数据,且其结构与已知的大鼠致癌物丙烯腈相似,美国国立癌症研究所将其提名为毒性和致癌性测试对象。当前进行的为期13周的研究是美国国家毒理学计划(NTP)评估甲基丙烯腈毒性和致癌性的整体工作的一部分。在为期13周的研究中,将20只雄性和20只雌性F344/N大鼠分为不同组,通过灌胃给予其每千克体重0、7.5、15、30、60或120毫克甲基丙烯腈的去离子纯净水。将20只雄性和20只雌性B6C3F1小鼠分为不同组,给予其每千克体重0、0.75、1.5、3、6或12毫克甲基丙烯腈。在第32天对每组中的10只雄性和10只雌性大鼠及小鼠进行评估。这些研究结果清楚地表明,雄性大鼠比雌性大鼠对甲基丙烯腈处理更敏感。在大鼠研究中,给予120毫克/千克的19只雄性和1只雌性大鼠以及给予60毫克/千克的2只雄性大鼠在研究的第一周死亡。在第32天中期评估和13周时,60毫克/千克组的雄性大鼠以及13周时120毫克/千克组的雌性大鼠的最终平均体重和体重增加量显著低于溶剂对照组;在第32天中期评估时,120毫克/千克组中存活的雄性大鼠体重也低于对照组。毒性的临床发现具有剂量依赖性,包括嗜睡、流泪、震颤、惊厥、共济失调和呼吸异常。有血液学证据表明,给予甲基丙烯腈会诱发轻度、正细胞、正色素性贫血。在第32天中期评估时,雄性和雌性大鼠的血细胞比容值、血红蛋白浓度和红细胞计数下降,证明存在与剂量相关的轻度贫血。这种贫血在第13周时有所改善。给予甲基丙烯腈导致雄性和雌性大鼠血清硫氰酸盐和血氰化物浓度与剂量相关增加。这些变化是预期的,并且与甲基丙烯腈在体内代谢为氰化物一致。雄性大鼠的血氰化物浓度通常高于雌性大鼠,这可能解释了雄性大鼠对甲基丙烯腈致死作用更敏感的原因。也有生化证据表明,给药的雄性大鼠肝细胞渗漏增加和/或功能改变,表明肝脏可能是甲基丙烯腈毒性作用的靶器官。与溶剂对照组相比,接受60毫克/千克的雄性大鼠在第32天中期评估时绝对右肾和胸腺重量略有但显著下降,在第13周时肝脏和胃重量增加。在第32天和第13周时,60和120毫克/千克组雌性大鼠的胃重量显著大于对照组,120毫克/千克组雌性大鼠的胸腺重量显著小于对照组;在第32天,120毫克/千克组雌性大鼠的肝脏重量也显著大于溶剂对照组。在第32天和研究结束时,给予60毫克/千克的雄性和雌性大鼠以及给予120毫克/千克的雌性大鼠鼻嗅上皮化生的发生率显著高于溶剂对照组;在第32天,60和120毫克/千克组雌性大鼠的嗅上皮坏死发生率也显著高于溶剂对照组。雌性大鼠的发生率和/或严重程度随剂量增加而增加;然而,给予120毫克/千克的雄性大鼠死亡率高,难以评估雄性大鼠的剂量反应关系。大鼠鼻腔的未观察到有害作用水平为30毫克/千克。给予60或120毫克/千克甲基丙烯腈的雌性大鼠的发情周期明显长于溶剂对照组。60毫克/千克组的雌性大鼠在间情期的时间比溶剂对照组更长。12毫克/千克组中有1只雄性和1只雌性小鼠过早死亡。给予甲基丙烯腈对最终平均体重或体重增加量没有显著差异。临床发现包括嗜睡、震颤、共济失调、惊厥和呼吸异常。在第32天中期评估时,给予3毫克/千克或更高剂量的雄性大鼠胃重量显著大于对照组,12毫克/千克组雄性大鼠的胸腺重量显著小于对照组。然而,在第13周时,仅12毫克/千克组雄性大鼠的胃重量相对于溶剂对照组增加。给予甲基丙烯腈的小鼠未出现与治疗相关的组织病理学病变。甲基丙烯腈在有或无S9激活的情况下,均未在几种鼠伤寒沙门氏菌菌株中诱导突变,并且在幼虫期喂食甲基丙烯腈的雄性黑腹果蝇生殖细胞中未诱导性连锁隐性致死突变。甲基丙烯腈对雄性大鼠和小鼠进行体内骨髓微核试验的结果也为阴性。总之,对大鼠和小鼠灌胃给予甲基丙烯腈会导致剂量依赖性的嗜睡、震颤、流泪、惊厥和呼吸异常。然而,这些影响在大鼠中比在小鼠中更明显;这些差异可能归因于给予大鼠的甲基丙烯腈剂量更高。大鼠的体重增加和存活数据表明,雄性大鼠比雌性大鼠对甲基丙烯腈给药更敏感。血氰化物浓度与存活率之间存在明显相关性,给予甲基丙烯腈的雄性大鼠氰化物浓度更高,存活率低于雌性大鼠。在显微镜下,甲基丙烯腈毒性的唯一靶器官是鼻腔的嗅上皮。每天接受60或120毫克/千克的雄性和雌性大鼠会出现坏死和化生效应。给予甲基丙烯腈的小鼠未观察到类似病变。给予甲基丙烯腈13周的雄性和雌性大鼠嗅上皮病变的未观察到有害作用水平为每天30毫克/千克。对给予甲基丙烯腈13周、每天剂量高达12毫克/千克的雄性或雌性小鼠,未观察到明显的化学相关影响。